<乌鸦传媒>Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survival News, features, and commentary about cancer-related issues Jun 16, 2021
<乌鸦传媒>The FDA Is Failing the American People The agency's recent decision to approve aducanumab offers more evidence of a broken system Jun 16, 2021
<乌鸦传媒>Docs, Scientists Call on FDA to Delay Approval of COVID Vaccines Data should be from completed phase III trials, not interim results, group says Jun 10, 2021
<乌鸦传媒>Op-Ed: Why Is Prescribing Information Still on Paper? Making electronic info the default is a small change with a big environmental impact Jun 04, 2021
<乌鸦传媒>Medtronic's LVAD Pulled From Market Due to Neurological, Mortality Risks Physicians must stop implanting the HeartWare system, says FDA Jun 03, 2021
<乌鸦传媒>Guns for Vaccinations; IU Health Joins the Mandate Club; NFL Ends 'Race-Norming' A daily roundup of news on COVID-19 and the rest of medicine Jun 03, 2021
<乌鸦传媒>Novel Aid to Help Diagnose Autism Gets FDA Nod Canvas Dx device may help early diagnoses and intervention in young children Jun 02, 2021
<乌鸦传媒>FDA OKs New Antipsychotic for Schizophrenia, Bipolar Disorder Approval of olanzapine-samidorphan carries opioid-related contraindications Jun 01, 2021
<乌鸦传媒>Are Vaccine Advisors More Conflicted Than We Thought? Rules for advisory committee members' disclosures vary widely May 28, 2021
<乌鸦传媒>Drug to Delay T1D Gets Tepid Endorsement by FDA Advisors Feelings mixed on safety and efficacy evidence for novel biologic May 28, 2021
<乌鸦传媒>FDA Restricts Ocaliva Use in Primary Biliary Cholangitis Liver failure, need for liver transplant reported in patients with advanced cirrhosis May 27, 2021
<乌鸦传媒>Bad Day Sunshine: Benzene Found in Many Sun Care Products Valisure also detected the carcinogen in hand sanitizers earlier this year May 26, 2021
<乌鸦传媒>FDA Draft Guidance on T2D Devices; New GLP-1 Drug Succeeds in Trial News and commentary from the endocrinology world May 23, 2021
<乌鸦传媒>House Dems Grill Emergent Execs Over Spoiled J&J Doses Mixed-up ingredients, wasted taxpayer dollars, potential insider training? May 20, 2021
<乌鸦传媒>Indian Variant a Global Risk; Good News on U.S. Cases; Baylor Expert Gets Threats A daily roundup of news on COVID-19 and the rest of medicine May 11, 2021
<乌鸦传媒>First COVID Treatment Ads Hit the Airwaves Regeneron hoping patients ask their doctors about monoclonal antibodies May 10, 2021
<乌鸦传媒>FDA Panel to Weigh Avacopan's Fate for ANCA Vasculitis Agency staff called out "interpretability" of phase III trial results ahead of Thursday's meeting May 05, 2021
<乌鸦传媒>Op-Ed: Is FDA's Cigarette Ban Just Smoke and Menthols? Actually implementing a ban on menthol cigarettes and cigars could take years May 03, 2021
<乌鸦传媒>Thumbs Up for New Birth Control Pill Across Multiple Subgroups No differences in efficacy or unscheduled bleeding based on age, BMI, or prior contraceptive use May 03, 2021
<乌鸦传媒>'It's a Straw-Man Argument': What We Heard This Week Quotable quotes from 乌鸦传媒's sources May 02, 2021
<乌鸦传媒>Farxiga Gets FDA Greenlight for CKD SGLT2 OK'd to prevent chronic kidney disease progression and cardiovascular risks Apr 30, 2021
<乌鸦传媒>FDA Panel Splits on Anti-PD-1 Monotherapy in HCC All thumbs up for pembrolizumab, pending further data, but no such luck for nivolumab Apr 30, 2021
<乌鸦传媒>PD-1 Inhibitor Approved for dMMR Endometrial Cancer Dostarlimab led to 42.3% response rate in recurrent/advanced disease Apr 22, 2021
<乌鸦传媒>ALS 'Compassionate Use' Again Hits National Media Expanded access campaigns will only become more frequent with growing rare disease pipelines Apr 20, 2021
<乌鸦传媒>Op-Ed: Addiction Is Killing Our Families Closing treatment knowledge gaps can help Apr 14, 2021
<乌鸦传媒>Another Player in Advanced Bladder Cancer Accelerated FDA approval of sacituzumab govitecan after chemo, immunotherapy Apr 14, 2021
<乌鸦传媒>CDC Issues Health Advisory on J&J Shot; Pfizer Ramps Up; STDs at All-Time High A daily roundup of news on COVID-19 and the rest of medicine Apr 14, 2021
<乌鸦传媒>FDA Temporarily Lifts Restriction on Abortion Pill Allows clinicians to dispense mifepristone via telehealth during the pandemic Apr 13, 2021
<乌鸦传媒>Donor Heart Preserver Survives Review by FDA Advisors Panel had many bones to pick with the Transmedics OCS device Apr 07, 2021
<乌鸦传媒>Common Hospital PCR Test Affected by Viral Variant Cepheid Xpert joins three other tests for which B.1.1.7 can be problematic Apr 05, 2021
<乌鸦传媒>FDA: Arrhythmia Risk With Lamotrigine May Be Class Effect Agency updates warning for people with cardiac disease taking sodium channel blockers Apr 01, 2021
<乌鸦传媒>Novel Device OK'd to Treat MS Gait Deficits Tongue stimulator generates pulses to combat ataxia Mar 26, 2021
<乌鸦传媒>Harmony Pulmonary Valve Gets FDA Nod Transcatheter valve implantation approved for people without surgical RVOT conduits Mar 26, 2021
<乌鸦传媒>Overactive Bladder Drug Gains Pediatric Indication Mirabegron approved to treat kids with neurogenic detrusor overactivity Mar 26, 2021
<乌鸦传媒>FDA Panel Unhappy With Novel OA Pain Drug Latest setback for troubled osteoarthritis biologic Mar 25, 2021
<乌鸦传媒>Benzene Found in Multiple Hand Sanitizer Brands Known human carcinogen can be absorbed through the skin Mar 25, 2021
<乌鸦传媒>Op-Ed: Blood Cancer Patients Need More COVID Vax Answers Patients are left wondering, "will I be protected?" Mar 24, 2021
<乌鸦传媒>Banned Stimulants Again Found in Supplements Researchers question FDA's commitment to enforcement Mar 23, 2021
<乌鸦传媒>Op-Ed: Now Isn't the Time to Ignore the Opioid Crisis Swift federal action can remove barriers to life-saving treatment Mar 06, 2021
<乌鸦传媒>FDA Warns Mercola for Selling Bogus COVID Treatments Controversial physician in trouble for claims about vitamin C, vitamin D, and quercetin products Mar 05, 2021
